Radiation Therapy Planning by Multi-parametric PET/MRI Imaging in patients with cervical cancer

Phase 1

• Conditions: cervical cancer; MedDRA version: 20.0Level: LLTClassification code 10008229Term: Cervical cancerSystem Organ Class: 100000004864; MedDRA version: 20.0Level: LLTClassification code 10008233Term: Cervical cancer stage ISystem Organ Class: 100000004864; MedDRA version: 20.0Level: LLTClassification code 10008234Term: Cervical cancer stage IISystem Organ Class: 100000004864; MedDRA version: 20.0Level: LLTClassification code 10008235Term: Cervical cancer stage IIISystem Organ Class: 100000004864; MedDRA version: 20.0Level: LLTClassification code 10008236Term: Cervical cancer stage IVSystem Organ Class: 100000004864; Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Diagnosis [E01]

• Registration Number: EUCTR2018-003072-12-DK
• Lead Sponsor: rigshospitalet

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-09-03
• Last Update Posted: 9 January 2023

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: 25

Inclusion Criteria

Inclusion criteria
•Diagnosed with cervical cancer stage IB2-IVA
•Tumor > 1cm
•Referred for EBRT and BT planning
•Age > 18 years
•Informed consent

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 10
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 15

Exclusion Criteria

??Exclusion criteria
•Prior RT of the pelvic region
•Pregnancy and lactation
•Claustrophobia
•MR-incompatible implants

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified